FDA panel backs Alexza drug with limits (Reuters)
Reuters – U. S. drug advisers recommended approving an experimental treatment from Alexza Pharmaceuticals for calming down patients with schizophrenia or bipolar disorder, but placed restrictions on how the drug should be used.
View full post on Yahoo! News: Health News
Leave a Reply